Effects of transitional care interventions on rehospitalization, functional outcomes, and quality of life in stroke survivors: an updated systematic review and meta-analysis of randomized controlled trials - Summary - MDSpire

Effects of transitional care interventions on rehospitalization, functional outcomes, and quality of life in stroke survivors: an updated systematic review and meta-analysis of randomized controlled trials

  • By

  • Xiaoqin Yang

  • Yan Han

  • Yuntian Liu

  • Na Zhao

  • Yan He

  • Feipeng Li

  • June 23, 2026

  • 0 min

Share

Objective:

To evaluate the effects of transitional care interventions on rehospitalization, functional outcomes, quality of life, mortality, and disability in stroke survivors.

Approach:
    Key Findings:
    • Transitional care interventions reduced overall rehospitalization (RR = 0.59, 95% CI 0.40–0.88).
    • More consistent effect on rehospitalization within 3 months post-discharge (RR = 0.49, 95% CI 0.29–0.82).
    • Improved activities of daily living (ADL) (SMD = 0.43, 95% CI 0.20–0.67), but with substantial heterogeneity.
    • Quality of life (QoL) improved overall (SMD = 0.67, 95% CI 0.37–0.96), particularly within 3 months (SMD = 0.74, 95% CI 0.54–0.94).
    • No significant reduction in mortality (RR = 0.86, 95% CI 0.53–1.39).
    • Lower short-term disability measured by the modified Rankin Scale (mRS; SMD = −0.59, 95% CI −0.99 to −0.19).
    Interpretation:

    Transitional care interventions may reduce short-term rehospitalization and improve short-term QoL in stroke survivors. They may also improve ADL and short-term disability, but findings should be interpreted cautiously due to heterogeneity and risk of bias.

    Limitations:
    • Substantial heterogeneity in ADL and disability outcomes.
    • Moderate certainty of evidence for short-term rehospitalization and QoL; low for ADL, mortality, and disability.
    • Potential small-study effects.
    Conclusion:

    Transitional care interventions may reduce short-term rehospitalization and improve short-term QoL in stroke survivors, but evidence regarding mortality benefit is unclear.

Original Source(s)

Related Content